About us

Meet our team

With some of the most talented experts in detoxification and bacterial vaccines combined with our experienced Board of Directors and scientific advisors, Proxi Biotech strives to overcome the challenges of multi-resitant bacteria

Management

Kasper Gubba Ørtenblad

CEO and co-founder

René Jørgensen PhD

CTO and co-founder

Aria Aminzadeh

CRO and co-founder

Board of Directors

Paul Hargreaves MBA

Chief Development Officer, ResoTher Pharma

Scientific advisors

Dr. Ed Kuijper MD PhD

Professor Emeritus, PI C. difficile,

Leiden University Medical Center

Karen Krogfel PhD

Professor, Molecular and Medical Biology, University of Roskilde

Copyright 2019 Proxi Biotech All Rights Reserved